Dyadic International Inc.

1.32
-0.06 (-4.35%)
At close: Mar 26, 2025, 12:51 PM
-4.35%
Bid 1.32
Market Cap 39.21M
Revenue (ttm) 3.37M
Net Income (ttm) -6.35M
EPS (ttm) -0.23
PE Ratio (ttm) -5.76
Forward PE -4.78
Analyst Buy
Ask 1.33
Volume 11,511
Avg. Volume (20D) 80,801.5
Open 1.38
Previous Close 1.38
Day's Range 1.32 - 1.33
52-Week Range 0.93 - 2.67
Beta 0.95

About DYAI

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific anti...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 16, 2008
Employees 7
Stock Exchange NASDAQ
Ticker Symbol DYAI
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for DYAI stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 352.83% from the latest price.

Stock Forecasts

Next Earnings Release

Dyadic International Inc. is scheduled to release its earnings on Mar 26, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription